Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMVDM0Q)
| Drug Name | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Nitraquazone; UNII-1YF1KXP4QF; 1YF1KXP4QF; 56739-21-0; Nitraquazonum; Nitraquazona; nitraquazone[inn]; Nitraquazone [INN]; Nitraquazonum [Latin]; Nitraquazona [Spanish]; AC1L2AEJ; CHEMBL88990; SCHEMBL125623; ZINC1819; AC1Q21K9; GNWCRBFQZDJFTI-UHFFFAOYSA-N; BDBM50218545; 3-ethyl-1-(3-nitrophenyl)quinazoline-2,4-dione; 3-Ethyl-1-(m-nitrophenyl)-2,4(1H,3H)-quinazolinedione; 1-(m-nitrophenyl)-3-ethylquinazoline-2,4 (1H, 3H)-dione; 1-(m-nitrophenyl)- 3-ethylquinazoline-2,4(1H, 3H)-dione; 1-(m-nitrophenyl)-3-ethylquinazoline-2,4(1H,
|
|||||||||||||||||||
| Indication |
|
|||||||||||||||||||
| Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
![]() Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
|||||||||||||||||||||||||||||||||
| Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
| The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||

